Knowledge graph-based approaches to drug repurposing for COVID-19

The COVID-19 pandemic has motivated researchers across the globe to find effective drugs and therapeutics for treating the disease. Many efforts have focused on repurposing existing drugs used for other illnesses to save time. The CAS Biomedical Knowledge Graph was developed to identify drugs that can be repurposed to treat COVID-19.

This peer-reviewed article published in the Journal of Chemical Information and Modeling examines this graph and its results in greater detail. It shows how various molecules were analyzed according to molecular function and clinical trials. This graph not only provides an opportunity to accelerate innovation and research for COVID-19 but many other diseases as well. Read the full publication here.

Read the full journal publication

Related CAS Insights

製薬分野の特許の状勢に関するCAS Insightsウェビナーのハイライト

免疫腫瘍学における新しいトランスレーショナルリサーチは、現在の治療法に反応しない患者に届く可能性があります。

CAS Insightsレポート:特許インテリジェンスを通じて製薬イノベーションの未来を切り拓く。

Gain new perspectives for faster progress directly to your inbox.